Insulin resistance in relation to lipids and inflammation in type-2 diabetic patients and non-diabetic people

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Feng, Ying Mei ^a   Zhao, Dong ^a   Zhang, Ning ^a   Yu, Cai Guo ^a   Zhang, Qiang ^a   Thijs, Lutgarde ^b   Staessen, Jan A ^b,c  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID; TRIACYLGLYCEROL; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; BELGIUM; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DYSLIPIDEMIA; ETHNIC DIFFERENCE; FEMALE; HUMAN; INFLAMMATION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NON INSULIN DEPENDENT DIABETES MELLITUS; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHINA; GLUCOSE BLOOD LEVEL; METABOLISM; MIDDLE AGED; PHYSIOLOGY;

ADULT; AGED; BELGIUM; BLOOD GLUCOSE; CHINA; CHOLESTEROL, HDL; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; INFLAMMATION; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; MIDDLE AGED; TRIGLYCERIDES;

EID: 84963775232     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153171     Document Type: Article

References (33)

1. Mooradian AD. Dyslipidemia in type 2 diabetes mellitus. Nat Clin Pract Endocrinol Metab. 2009; 5:150-159. doi: 10.1038/ncpendmet1066 PMID: 19229235
2. Hong EG, Ko HJ, Cho YR, Kim HJ, Ma Z, Yu TY, et al. Interleukin-10 prevents diet-induced insulin resistance by attenuating macrophage and cytokine response in skeletal muscle. Diabetes. 2009; 58:2525-2535. doi: 10.2337/db08-1261 PMID: 19690064
3. Perry RJ, Camporez JP, Kursawe R, Titchenell PM, Zhang D, Perry CJ, et al. Hepatic acetyl CoA links adipose tissue inflammation to hepatic insulin resistance and type 2 diabetes. Cell. 2015; 160:745-758. doi: 10.1016/j.cell.2015.01.012 PMID: 25662011
4. Taskinen MR, Boren J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015; 239:483-495. doi: 10.1016/j.atherosclerosis.2015.01.039 PMID: 25706066
5. Van Gassen N, Staels W, Van Overmeire E, De Groef S, Sojoodi M, Heremans Y, et al. Concise Review: Macrophages: Versatile Gatekeepers During Pancreatic beta-Cell Development, Injury, and Regeneration. Stem Cells Transl Med. 2015; 4:555-563. doi: 10.5966/sctm.2014-0272 PMID: 25848123
6. Feng Y, Schouteden S, Geenens R, Van Duppen V, Herijgers P, Holvoet P, et al. Hematopoietic stem/progenitor cell proliferation and differentiation is differentially regulated by high-density and low-density lipoproteins in mice. PLoS One. 2012; 7:e47286. doi: 10.1371/journal.pone.0047286 PMID: 23144813
7. Lastra G, Sowers JR. Obesity and cardiovascular disease: Role of adipose tissue, inflammation, and the renin-angiotensin-aldosterone system. Horm Mol Biol Clin Investig. 2013; 15:49-57. doi: 10.1515/hmbci-2013-0025 PMID: 25436732
8. Vella CA, Burgos X, Ellis CJ, Zubia RY, Ontiveros D, Reyes H, et al. Associations of insulin resistance with cardiovascular risk factors and inflammatory cytokines in normal-weight Hispanic women. Diabetes Care. 2013; 36:1377-1383. doi: 10.2337/dc12-1550 PMID: 23275356
9. Lee CT, Harris SB, Retnakaran R, Gerstein HC, Perkins BA, Zinman B, et al. White blood cell subtypes, insulin resistance and beta-cell dysfunction in high-risk individuals-the PROMISE cohort. Clin Endocrinol (Oxf). 2014; 81:536-541.
10. Yudkin JS, Stehouwer CD, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: Associations with obesity, insulin resistance, and endothelial dysfunction: A potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19:972-928. PMID: 10195925
11. Gower BA, Goss AM. A lower-carbohydrate, higher-fat diet reduces abdominal and intermuscular fat and increases insulin sensitivity in adults at risk of type 2 diabetes. J Nutr. 2015; 145:177S-183S. doi: 10.3945/jn.114.195065 PMID: 25527677
12. Liu LF, Kodama K, Wei K, Tolentino LL, Choi O, Engleman EG, et al. The receptor CD44 is associated with systemic insulin resistance and proinflammatory macrophages in human adipose tissue. Diabetologia. 2015;1579-1586. doi: 10.1007/s00125-015-3603-y PMID: 25952479
13. McCann JC, Shigenaga MK, Mietus-Snyder ML, Lal A, Suh JH, Krauss RM, et al. A multicomponent nutrient bar promotes weight loss and improves dyslipidemia and insulin resistance in the overweight/obese: Chronic inflammation blunts these improvements. FASEB J. 2015; 29:3287-3301. doi: 10.1096/fj.15-271833 PMID: 25900806
14. Tian JY, Yang Y, Cheng Q, Huang HE, Li R, Jiang GX, et al. Association of WBC count and glucose metabolism among Chinese population aged 40 years and over. Diabetes Res Clin Pract. 2008; 82:132-138. doi: 10.1016/j.diabres.2008.05.014 PMID: 18691786
15. De Vries MA, Alipour A, Klop B, Van De Geijn GJ, Janssen HW, Njo TL, et al. Glucose-dependent leukocyte activation in patients with type 2 diabetes mellitus, familial combined hyperlipidemia and healthy controls. Metabolism. 2015; 64:213-217. doi: 10.1016/j.metabol.2014.10.011 PMID: 25456098
16. Li Y, Zagato L, Kuznetsova T, Tripodi G, Zerbini G, Richart T, et al. Angiotensin-converting enzyme I/D and alpha-adducin Gly460Trp polymorphisms: From angiotensin-converting enzyme activity to cardiovascular outcome. Hypertension. 2007; 49:1291-1297. PMID: 17452507
17. Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009; 150:604-612. PMID: 19414839
18. Johnson R, McNutt P, MacMahon S, Robson R. Use of the Friedewald formula to estimate LDL-cholesterol in patients with chronic renal failure on dialysis. Clin Chem. 1997; 43:2183-2184. PMID: 9365406
19. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013; 34:2159-2219. doi: 10.1093/eurheartj/eht151 PMID: 23771844
20. Siebel AL, Heywood SE, Kingwell BA. HDL and glucose metabolism: Current evidence and therapeutic potential. Front Pharmacol. 2015; 6:258. doi: 10.3389/fphar.2015.00258 PMID: 26582989
21. Shim WS, Kim HJ, Kang ES, Ahn CW, Lim SK, Lee HC, et al. The association of total and differential white blood cell count with metabolic syndrome in type 2 diabetic patients. Diabetes Res Clin Pract. 2006; 73:284-291. PMID: 16563549
22. Tong PC, Lee KF, So WY, Ng MH, Chan WB, Lo MK, et al. White blood cell count is associated with macro-and microvascular complications in chinese patients with type 2 diabetes. Diabetes Care. 2004; 27:216-222. PMID: 14693992
23. Barter PJ, Nicholls S, Rye KA, Anantharamaiah GM, Navab M, Fogelman AM. Antiinflammatory properties of HDL. Circ Res. 2004; 95:764-772. PMID: 15486323
24. Kontush A. HDL-mediated mechanisms of protection in cardiovascular disease. Cardiovasc Res. 2014; 103:341-349. doi: 10.1093/cvr/cvu147 PMID: 24935434
25. Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM, De Craen AJ, et al. Statins and risk of incident diabetes: A collaborative meta-analysis of randomised statin trials. Lancet. 2010; 375:735-742. doi: 10. 1016/S0140-6736(09)61965-6 PMID: 20167359
26. Hu M, Yang YL, Masuda D, Yamashita S, Tomlinson B. Effect of Extended-Release Niacin/Laropiprant Combination on Plasma Adiponectin and Insulin Resistance in Chinese Patients with Dyslipidaemia. Dis Markers. 2015; 2015:154014. doi: 10.1155/2015/154014 PMID: 26063948
27. Larsen CM, Faulenbach M, Vaag A, Volund A, Ehses JA, Seifert B, et al. Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med. 2007; 356:1517-1526. PMID: 17429083
28. Sloan-Lancaster J, Abu-Raddad E, Polzer J, Miller JW, Scherer JC, De Gaetano A, et al. Double-blind, randomized study evaluating the glycemic and anti-inflammatory effects of subcutaneous LY2189102, a neutralizing IL-1beta antibody, in patients with type 2 diabetes. Diabetes Care. 2013; 36:2239-2246. doi: 10.2337/dc12-1835 PMID: 23514733
29. Dalmas E, Venteclef N, Caer C, Poitou C, Cremer I, Aron-Wisnewsky J, et al. T cell-derived IL-22 amplifies IL-1beta-driven inflammation in human adipose tissue: Relevance to obesity and type 2 diabetes. Diabetes. 2014; 63:1966-1977. doi: 10.2337/db13-1511 PMID: 24520123
30. Talukdar S, Oh da Y, Bandyopadhyay G, Li D, Xu J, McNelis J, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med. 2012; 18:1407-1412. PMID: 22863787
31. Mansuy-Aubert V, Zhou QL, Xie X, Gong Z, Huang JY, Khan AR, et al. Imbalance between neutrophil elastase and its inhibitor alpha1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure. Cell Metab. 2013; 17:534-548. doi: 10.1016/j.cmet.2013.03.005 PMID: 23562077
32. Wang Q, Xie Z, Zhang W, Zhou J, Wu Y, Zhang M, et al. Myeloperoxidase deletion prevents high-fat diet-induced obesity and insulin resistance. Diabetes. 2014; 63:4172-4185. doi: 10.2337/db14-0026 PMID: 25024373
33. Andrade VL, Petruceli E, Belo VA, Andrade-Fernandes CM, Caetano Russi CV, Bosco AA, et al. Evaluation of plasmatic MMP-8, MMP-9, TIMP-1 and MPO levels in obese and lean women. Clin Biochem. 2012; 45:412-415. doi: 10.1016/j.clinbiochem.2012.01.008 PMID: 22285381